Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Yes its bS .. 1.18 to buy anything over £600 and can't get a quote for any less... they're just trying to scare people out of their shares.
F-in posts
ballbag was all that was needed tbf... seems to set off a right post cluster.
4 days.
Are we rich beyond all our wildest capatilisum selfish dreams & suuing jeff Bezos for being bald and a greedy tw at....
Or off to sign a giro.
The god of aim will decide.
Or maybe a podcast... clearly know their stuff.
Or some random rampers...
The science ?
F me maybe even trump, might tag the tw at in a post... worth a shot.
S*it. Serious stuff.
Sherka.
Nothing’s guaranteed & the most important thing is to remain in the game, capital protection, if this in the ultimately very unlikely event fell through, you can make it back elsewhere.
At what price you sell or slice is an entirely personal decision & very much depends on what price you got in at.
Almost 300% up I would certainly be taking my original out. Which is very likely what most of the sells we are seeing are.
Never understand why anyone puts sell targets on a public forum.
Your competition & mom’s can read, you are giving away info that doesn’t need to be diverged, giving to much info to people that can use it to their advantage.
Market makers read these boards, they even have trolls on these boards.
Keep some stuff to yourself it’ll fare you far better....
Dunno, but, probably worth cashing out before market catches up.
To buy any of these online, had to ring the dealing desk, but given current state of economy/U prices and political landscape , such a tiny mcap and potential for an obscene rise well worth a punt.
Just to add Tom.
If the pharm2farm masks POC is confirmed, (hopefully this week) with brh’s % holding on rms it would almost completely de risk buying in around these levels even with the very unlikely matter the test isn’t as good etc as expected & news on the 16th lets us down.
Add in Brh & RMS’s other opportunities A £14m mcap is obscene given the possible upside.
Yep that is defo a buy aswel.
Wind back on a 5m chart and it was the highest price paid up till that time.
Newbie - unlike any of the competition there is a real possibility that this, handheld 90? Second test could be adapted & used with many future virus/disease etc.
We’re yet to have this confirmed at any meaningful level but as others said earlier in the day Carl’s posts on twitter really do add a large level of confidence For us holders.
Confirmation on adaption, partners, joint ventures, government funding, buy out or whatever it may be £3 would only be around £120m mcap from this level.
In comparison to other tests, which wouldn’t be as good, doesn’t seem So much of a pipe dream. Imo. But we’ll see.
Sorry. That reply was to both.
75p a test at 1m a month with no adaptability ain’t going to prop a £188m mcap up for long imo but I don’t know what else they are doing so my view isn’t as researched as many.
Shardster - agree with the migration of funds mate, people need to look at the mcap comparison & not the size rise & I’m sure they will & are starting to notice. The professor weighing in certainly helps imo.
As far as testing goes. Imo they won’t step it up till after brexit as they have another scapegoat hence why it’s been such an abominable s/show. At some point tho for sure.
If the tech here is adaptable as far as I’m concerned this s**ts all over the other tests out there as it won’t just dry up once Covid is under control.